FDA panel recommends allowing birth control pill to be sold over the counter

May 10

USA Today covers an FDA advisory panel’s unanimous recommendation for the agency to approve Opill, a daily progestin-only birth control pill, for over the counter use.

FDAOTC accessprogestin-only pillsUnited States

Free the Pill

FDA panel recommends allowing birth control pill to be sold over the counter

FDA advisors ok approval of first over-the-counter birth control pill

The FDA considers first birth control pill without a prescription